A new study has found that performing well on two brief tests measuring cognitive ability and ability to identify odors indicates very low risk for Alzheimer’s.
Dr. Kathleen M. Pike highlights Dementia Reimagined, a book that can help us understand the complex interplay of biology and environment in putting us at risk for dementia.
Optimizing Outcomes of Treatment-Resistant Depression in Older Adults (OPTIMUM) is the largest study ever done on late-life depression. OPTIMUM’s New York site is located at NYSPI/Columbia.
A clinical trial conducted by Columbia University and Duke University suggest that donepezil may not improve cognitive performance in people at risk for Alzheimer’s disease who also had depression.
Researchers at Columbia University Medical Center and New York State Psychiatric Institute may have discovered a way to use a patient’s sense of smell to treat Alzheimer’s disease before it develops.
“As the ‘silver tsunami’ approaches, substance use disorders in the elderly are expected to more than triple by 2020,” says Dr. Kotbi, Associate Professor of Psychiatry